Press Releases Items Per Page 102550 News Category FinancialGeneral Year None202020192018201720162015201420132012201120102009200820072006 Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol Jan 14, 2020 Nektar Therapeutics and Bristol-Myers Squibb Amend Strategic Collaboration Agreement for bempegaldesleukin Plus Opdivo (nivolumab) Jan 10, 2020 Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 07, 2020 Nektar Therapeutics Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D. Dec 17, 2019 Nektar Therapeutics Announces Presentation of New Preclinical Data for its IL-15 Agonist, NKTR-255, at the American Society of Hematology (ASH) 2019 Annual Meeting Dec 09, 2019 Nektar Appoints John Northcott as Chief Commercial Officer Dec 03, 2019 Nektar to Webcast Presentation at Jefferies 2019 London Healthcare Conference Nov 13, 2019 Nektar Therapeutics Presents Data from First-in-Human Phase 1a Study on Novel T Regulatory Cell Stimulator, NKTR-358 at 2019 Annual Meeting of the American College of Rheumatology Nov 10, 2019 Nektar Therapeutics Presents New Clinical and Preclinical Data from its Immuno-Oncology Pipeline at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting Nov 09, 2019 Nektar Therapeutics Reports Financial Results for the Third Quarter of 2019 Nov 06, 2019 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »